Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[The chlamydia epidemics is continuing--what should be done?]

Jorma Paavonen¹

¹HYKS:n naistenklinikka Haartmaninkatu 2 00290 Helsinki. jorma.paavonen@helsinki.fi

Duodecim; Laaketieteellinen Aikakauskirja

|September 21, 2002

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Serum IgG1 and IgG3 Antibodies to Chlamydia trachomatis Pgp3 and Hsp60 in Men of Subfertile Couples.

The Journal of infectious diseases·2025

Same author

Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review.

Human vaccines & immunotherapeutics·2025

Same author

Serum IgG1 and IgG3 Antibody Responses to Chlamydia trachomatis Pgp3 and Hsp60 in Tubal Factor Infertility.

The Journal of infectious diseases·2025

Same author

Localized provoked vulvodynia as an immune-mediated inflammatory disease: rationale for a new line of research.

Frontiers in cellular and infection microbiology·2025

Same author

Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma <i>in situ</i>-population-based follow-up of two cluster-randomized trials.

Frontiers in cellular and infection microbiology·2024

Same author

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study.

NPJ vaccines·2024